AbbVie lifts profit target after cancer drug powers third-quarter beat

AbbVie Inc beat Wall Street estimates for third-quarter profit and raised its earnings forecast for the year on Friday, driven by strong sales of blockbuster cancer medicine Imbruvica.

Powered by WPeMatico

Scroll to top